The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 25,501–25,600 of 31,469
Elevated asprosin in hypertension: evidence from an exploratory case-control study
Alkhalidy, H., Assamak, A., Al-Shami, I. K., Mukattash, T. L., Khashman, T., & Liu, D. (2026) · Scientific Reports · doi:10.1038/s41598-025-32824-y · Cited by 3
Moore, A. G. S., & Okoduwa, S. I. R. (2026) · Scientific Reports · doi:10.1038/s41598-025-33982-9 · Cited by 3
Acupuncture of polycystic ovary syndrome: delving into bile acid metabolism
Zhang, H., Chen, Y., Heng, D., Luo, J., Wang, H., Wang, W., Huo, Z., Wei, R., Ye, Y., Long, X., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-025-01297-6 · Cited by 4
Bruzina, A. S., Crum, B. A., Goodman, L. A., Ng, Y. E., Hawe, R. L., Call, J. A., & Greising, S. M. (2026) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00259.2025 · Cited by 3
Capra, B. T., Hudson, S., Phillips, K. M., Marinik, E. L., Laskaridou, E., Johnson, A. L., Wilson, E. A., Dong, M., David, L. A., Ives, N., et al. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101370 · Cited by 4
Alcubierre, D. D., Ferrari, D., Tomaselli, A., Moscucci, F., Bonaventura, I., Francia, A. L., Vozza, E., Lospinuso, I., Ettorre, E., Hasenmajer, V., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag018 · Cited by 5
Fang, Y., Li, H., Dong, P., & Wan, F. (2026) · BMC Public Health · doi:10.1186/s12889-026-26484-4 · Cited by 3
Walusimbi, B., Lawson, M. A., Bancroft, A. J., Nassuuna, J., Trivedi, D. K., Taylor, G., Sanya, R. E., Webb, E. L., Kateete, D. P., Grencis, R. K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68983-3 · Cited by 4
Waist Circumference as a Predictor of Hepatic Steatosis and Fibrosis in the NHANES 2017–2018 Cohort
Janakiram, N., Puri, S., & Thirumalai, A. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261419363 · Cited by 3
Hao, S., Zhang, Y., Li, L., et al. (2026) · Journal of International Medical Research · doi:10.1177/03000605261416741 · Cited by 3
Zhang, T., Liu, L., Zhang, Q., Jiang, W. H., Huang, Y., Ye, W., Zhang, N., & Zhang, J. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141652 · Cited by 3
Kim, Y., Ha, J., & Moon, J. S. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2026.0034 · Cited by 3
Giuffrè, G. M., Scalese, A., QUARANTA, D., Donnarumma, F., Vita, M. G., Carrozza, C., Rossini, P. M., Calabresi, P., & Marra, C. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107352 · Cited by 3
Siani, M., Bonfiglio, C., Bonfrate, L., Donghia, R., & Pastore, M. N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1797230 · Cited by 4
Gugliandolo, S., Morciano, C., Leccisotti, L., Capece, U., Giuseppe, G. D., Mezza, T., Ciccarelli, G., Soldovieri, L., Brunetti, M., AVOLIO, A., et al. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70162 · Cited by 3
Corapi, S., Runchey, M.-C., Lyons, J., de Leon, M. A., Pavlou, V., Lin, S., Ezpeleta, M., Gabel, K., Tussing-Humphreys, L. M., Oddo, V. M., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04316-7 · Cited by 9
Aramwit, P., Bunmee, P., & Supasyndh, O. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.10.002 · Cited by 3
Mekaru, K., Oishi, S., Akamine, K., Kinjo, T., Heshiki, C., Masamoto, H., & Aoki, Y. (2016) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2016.63020 · Cited by 2
Inositol versus Metformin administration in polycystic ovary syndrome patients
Hamid, A. M. S. A., Madkour, W. A. I., & Borg, T. F. (2015) · Evidence Based Women s Health Journal · doi:10.1097/01.ebx.0000466599.33293.cf · Cited by 3
Soori, R., Safei, A., Pournemati, P., & Ghram, A. (2018) · Sport Sciences for Health · doi:10.1007/s11332-018-0462-1 · Cited by 3
Morotti, E., Artini, P. G., Persico, N., & Battaglia, C. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1613361 · Cited by 3
Iqbal, S., Shah, S. I. A., & Sikandar, M. Z. (2019) · The Professional Medical Journal · doi:10.29309/tpmj/2019.26.11.237 · Cited by 3
Effect of bariatric surgery on glycemic profiles in multiethnic obese nondiabetic Asians
Teh, J. L., Leong, W. Q., Tan, Y. Z., So, J. B. Y., Kim, G., & Shabbir, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.11.017 · Cited by 3
Kazé, A. D., Musani, S. K., Bidulescu, A., Joseph, J. J., Correa, A., Ndumele, C. E., Bertoni, A. G., Ahima, R. S., Golden, S. H., & Echouffo-Tcheugui, J. B. (2020) · Diabetic Medicine · doi:10.1111/dme.14465 · Cited by 3
The insulin resistance indices: necessity and opportunities in type 2 diabetes mellitus management
Sorokina, Y. А., Занозина, О. В., & Postnikova, A. D. (2020) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2020-98-7-529-535 · Cited by 3
Hrubeniuk, T. J., Hay, J. L., MacIntosh, A., Wicklow, B. A., Wittmeier, K. D. M., McGavock, J., & Sénéchal, M. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0707 · Cited by 3
Giudici, K. V., de França, N. A. G., Peters, B. S. E., Fisberg, R. M., & Martini, L. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00849-5 · Cited by 3
Chemaga Nkonpawa, C., Moor, V. J. A., Tankeu, A. T., Momo, A. S., Wafeu, G. S., Amazia, F., Nkeck, J. R., Manases, T., Sama, J. D., & Choukem, S. P. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s313193 · Cited by 4
Muresan, A. A., Rusu, A., Pop, R. M., et al. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0033 · Cited by 3
Ram, H., Anand, K. K., Kashyap, P. M. K., et al. (2019) · INDIAN DRUGS · doi:10.53879/id.56.11.11780 · Cited by 3
Du, R., Li, L., Li, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.852395 · Cited by 3
Oza, C. M., Karguppikar, M. B., Khadilkar, V. V., Gondhalekar, K. M., & Khadilkar, A. V. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102453 · Cited by 3
Insulin Resistance in Obese Adolescents at a Tertiary care hospital in Bangladesh
Parvin, R., Begum, S., Mazumder, A. B. M. O. H., Jahan, I., & Shyamaly, K. J. (2022) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v47i2.57782 · Cited by 6
Encabo, P. G., Wilson, R. L., Kang, D., Norris, M. K., Uno, H., Christopher, C. N., Chow, C. R., Sami, N., Fox, F., Ligibel, J. A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.864844 · Cited by 3
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Karimi, M., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.12643 · Cited by 4
Farghaly, H. S., Metwalley, K. A., Gamal, Y. A., Saied, G. M., & Abdel-Raheem, Y. F. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2022.41 · Cited by 3
Molinari, M., Cremaschi, A., Iorio, M. D., Chaturvedi, N., Hughes, A. D., & Tillin, T. (2022) · Journal of Applied Statistics · doi:10.1080/02664763.2022.2116746 · Cited by 3
Azócar-Gallardo, J., Ramírez‐Campillo, R., Afonso, J. R., Sá, M., Granacher, U., González-Rojas, L., Ojeda-Aravena, A., & García‐García, J. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114331 · Cited by 4
Khodarahmi, M., Siri, G., Erahimzadeh, F., Farhangi, M. A., & Shanehbandi, D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01188-z · Cited by 3
Metabolic syndrome and Visceral Adiposity Index in non-functional adrenal adenomas
Karataş, S., Hacıoğlu, Y., & Beysel, S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000547 · Cited by 3
Far North residents’ age-related peculiarities based on construction of functional state matrices
Averyanova, I. V., Lugovaya, E. A., Вдовенко, С. И., & Barbaruk, Y. V. (2023) · Экология человека · doi:10.17816/humeco111891 · Cited by 4
Matsushima‐Nagata, K., Matsumura, T., Kondo, Y., Anraku, K., Fukuda, K., Yamanaka, M., Manabe, M., Irie, T., Araki, E., & Sugiuchi, H. (2023) · Biomolecules · doi:10.3390/biom13030468 · Cited by 4
Yuliasih, Y., Handoyo, M., Rahmawati, L. D., et al. (2023) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/24755303231180508 · Cited by 3
Triglyceride-Glucose Index as an Alternative Tool for Identifying Prediabetes and Insulin Resistance
Chowdhury, S. R., Siddiki, A. Z., & Kamrul-Hasan, A. B. M. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_4_23 · Cited by 4
Christensen, S. H., Rom, A. L., Greve, T., Lewis, J. I., Frøkiær, H., Allen, L. H., Mølgaard, C., Renault, K. M., & Michaelsen, K. F. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1223753 · Cited by 3
Insulin Resistance in Patients with Polycystic Ovary Syndrome is a Predictor of Fibromyalgia
Balsak, B. Ö. T., Fakı, S., Polat, Ş. B., Orhan, K., Koparal, S. S., Keskin, M., Topaloğlu, O., Ersoy, R., & Çakır, B. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01347-0 · Cited by 3
Desnutrin as a Biomarker for Insulin Resistance in Patients with Vitiligo Vulgaris
El‐Hamd, M. A., Sedky, A., Mahmoud, A. B., & El-Magid, W. M. A. (2023) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_435_22 · Cited by 3
The Prognosis of Glutamic Acid Decarboxylase Antibodies in Women With Hyperglycemia in Pregnancy
Cosson, E., Thioye, E. M. M., Tatulashvili, S., Vicaut, É., Larger, É., Sal, M., Pinto, S., Fabre, E. E., Lalatonne, Y., Sutton, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad617 · Cited by 4
Taharboucht, S., Guermaz, R., Brouri, M., Bengherbia, L., & Chibane, A. (2023) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2023.10.006 · Cited by 3
Zhuo, Y., He, J., Liangbing, W., Chow, C. B., & Ho, F. K. W. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.11.016 · Cited by 3
Pérez‐Hernández, N., Posadas‐Sánchez, R., Vargas‐Alarcón, G., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120610 · Cited by 3
Andriankaja, O. M., JOSHIPURA, K. J., Levine, M. A., Ramírez‐Vick, M., Rivas-Agosto, J. A., Duconge-Soler, J., & Graves, D. T. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231213252 · Cited by 3
Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Marinez, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01378-z · Cited by 4
Bisphenol A and cardiometabolic risk in adolescents: Data from the Generation XXI cohort
Magalhães, V., Severo, M., Costa, S. A., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.01.007 · Cited by 3
Matlock, K. A., Pérez‐Escamilla, R., & Wagner, J. A. (2024) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-024-01582-w · Cited by 3
Zhao, C., Liu, H., Deng, Y., Wu, H., Wang, S., Lyu, X., Lei, J., Yang, H., Hu, M., Zhao, Y., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111111 · Cited by 3
Denfeld, Q. E., Daelman, B., & Butts, B. (2024) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvae020 · Cited by 3
Agius, R., Pace, N. P., & Fava, S. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/5528250 · Cited by 2
Zhao, Y., Xiong, S., Liu, T., Shu, J., Zhu, T., Li, S., Zhong, M., Zhao, S., Huang, X., & Liu, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355703 · Cited by 3
Tremblay, È.-J., Peyrel, P., Karelis, A. D., RABASA-LHORET, R. P. R., Tchernof, A., Joanisse, D. R., & Mauriège, P. (2024) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0279 · Cited by 3
Discriminating insulin resistance in middle-aged nondiabetic women using machine learning approaches
Xing, Z., Chen, H., & Alman, A. C. (2024) · AIMS Public Health · doi:10.3934/publichealth.2024034 · Cited by 4
Sola, D., Bellan, M., Mai, S., Minisini, R., Perazzi, M., Brunani, A., Gentilli, S., Sainaghi, P. P., Scacchi, M., & Marzullo, P. (2024) · Medical Science Monitor · doi:10.12659/msm.944462 · Cited by 3
Atkins, R. M., Pantalia, M., Skaggs, C., Lau, A. K., Mahmood, M. B., Anwar, M. M., Barron, L., Eby, B. K., Khan, U., Tsiokas, L., et al. (2024) · Biology Open · doi:10.1242/bio.060280 · Cited by 3
Hamasaki, A., Harada, N., Muraoka, A., Yamane, S., Joo, E., Suzuki, K., & Inagaki, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1301352 · Cited by 3
Kose, M. P., Pişkinpaşa, M. E., Hacıoğlu, Y., et al. (2024) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2024-0024 · Cited by 3
Association between serum vitamin C and body mass index in adolescents aged 12–19 years
Su, X., Patel, N. D., Chen, J., Chen, Y., Zhou, X., Mo, X., & Zhu, S. (2024) · BMC Public Health · doi:10.1186/s12889-024-19588-2 · Cited by 3
Barragán-Zarate, G. S., Lagunez-Rivera, L., Alexander-Aguilera, A., et al. (2024) · Foods · doi:10.3390/foods13152432 · Cited by 3
Chen, P., Sun, Q., Xu, L., Li, F.-F., & Liu, H. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111805 · Cited by 3
Hu, T., Xu, Y., Li, X., Xiao, Y., Wang, Y., Bao, Y., & Ma, X. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae531 · Cited by 3
Andersson-Hall, U. K., Kristiansson, E., Zander, M., Wallenius, K., Sengpiel, V., & Holmäng, A. B. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111831 · Cited by 3
Different aspects of immunological profile in patients with Non-Alcoholic Fatty liver disease.
Osman, H. A., Tag-Adeen, M., Abdelaal, U., Elgezawy, E., Nasif, K. A., & Nafady, A. (2024) · Acta gastro-enterologica Belgica · doi:10.51821/87.2.12205 · Cited by 3
Jeong, I., Choi, K. M., Han, K. A., Kim, K., Kim, I. J., Han, S. J., Lee, W., & Yoo, S. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15838 · Cited by 4
Hewage, N., Wijesekara, U., & Perera, R. (2024) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2024.101783 · Cited by 3
Reed, B. L., Tavoian, D., Bailey, E. F., Funk, J. L., & Coletta, D. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1383131 · Cited by 3
Lee, M. J., Bae, J. H., Khang, A. R., Yi, D., Kim, J. Y., Kim, S. H., Kim, D. H., Kang, D., Park, S., Jeon, Y. K., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae632 · Cited by 3
Crommen, S., Rheinwalt, K. P., Plamper, A., Rösler, D., Weinhold, L., Metzner, C., & Egert, S. (2024) · Nutrients · doi:10.3390/nu16183210 · Cited by 4
Segala, A., Vezzoli, M., Vetturi, A., Garrafa, E., Zanini, B., Bottani, E., Marullo, M., Marconi, S., Ricci, C., & Valerio, A. (2024) · Diagnostics · doi:10.3390/diagnostics14182041 · Cited by 3
Sakamoto, S., Kakehi, S., Abudurezake, A., Kaga, H., Someya, Y., Tabata, H., Yoshizawa, Y., Naito, H., Tajima, T., Ito, N., et al. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241280540 · Cited by 3
Emir, S. N., & Emir, S. (2024) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1461623 · Cited by 3
Insulin Resistance after Fontan Palliation
Shea, E. V., Yu, S., Schumacher, K. R., Lowery, R., Doman, T., & Rocchini, A. P. (2024) · Pediatric Cardiology · doi:10.1007/s00246-024-03663-x · Cited by 3
Qiu, Y., Fan, S., Liu, J., He, X., Zhu, T., Li, Y., & Ren, M. (2024) · Clinical Cardiology · doi:10.1002/clc.70020 · Cited by 3
Serum Adropin Levels Are Elevated in Patients With Hyperthyroidism
Wang, X., Chang, X., Wang, Q., Ding, X., Wang, J., Cui, R., Wang, G., & Liu, J. (2024) · International Journal of Endocrinology · doi:10.1155/2024/7144798 · Cited by 3
Bayona, A., Pascual, E. L., Vicente‐Santamaría, S., et al. (2024) · Diabetology · doi:10.3390/diabetology5060040 · Cited by 3
da Silva, J. V. M. B., Veiga, A. C., Philbois, S. V., Ribeiro, V. B., Aguilar, B. A., Paixão, T. E. V., Chinellato, N. T., Delgado, J. C. S., Gastaldi, A. C., & de Souza, H. C. D. (2024) · Clinical Endocrinology · doi:10.1111/cen.15163 · Cited by 3
de Andrade, O. G. C., Castro, L. C., & Amado, V. M. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107859 · Cited by 3
Soares, T. D. C., Cardoso, B. E. P., Dias, T. M. D. S., Morais, J. B. S., Fontenelle, L. C., Melo, S. R. D. S., dos Santos, L. R., de Sousa, T. G. V., Sousa, M. D. P., de Oliveira, F. E., et al. (2024) · Nutrition and Health · doi:10.1177/02601060241296004 · Cited by 3
The Role of Intersectional Stigma in Coronary Artery Disease Among Cisgender Women Aging with HIV
Glynn, T. R., Larson, M. E., Bernal, M., Satish, S., O’Reilly, C. C., Nogueira, N. F., Zetina, A. S., Hurtado, V., Inestroza, K., Kedia, S. A., et al. (2024) · Behavioral Medicine · doi:10.1080/08964289.2024.2429073 · Cited by 3
Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy Syndromes
Krienke, M., Kralisch, S., Wagner, L., Tönjes, A., & Miehle, K. (2024) · Biomolecules · doi:10.3390/biom14111474 · Cited by 3
Wu, A., Pu, J., Emery, A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16099 · Cited by 3
Identification of Adipsin as a Biomarker of Beta Cell Function in Patients with Type 2 Diabetes
Park, J., Nguyen, T. N., Shim, H. M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237351 · Cited by 3
Methoden zur Abschätzung der Insulinresistenz
Blüher, M. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-1780-4148 · Cited by 3
Dantoft, T. M., Jørgensen, S. W., Wellnitz, K. B., Ørnbøl, E., Gormsen, L. K., Fink, P., Linneberg, A. R., Jørgensen, N. R., Petersen, M. W., Bjerregaard, A. A., et al. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107258 · Cited by 3
Francini‐Pesenti, F., Favaretto, S., D’Angelo, M., Cacciapuoti, M., & Calò, L. A. (2024) · Nutrients · doi:10.3390/nu16244324 · Cited by 3
Gizaw, G., Wells, J. C. K., Argaw, A., Olsen, M. F., Abdissa, A., Asres, Y., Challa, F., Berhane, M., Abera, M., Sadler, K., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.12.014 · Cited by 3
Buscemi, C., Randazzo, C., Barile, A. M., Caldarella, R., Murro, I., Caruso, R., Colombrita, P., Lombardo, M., Pergola, G. D., & Buscemi, S. (2025) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2024.2446886 · Cited by 4
Biswas, S., Hilser, J. R., Woodward, N. C., Wang, Z., Gukasyan, J., Nemet, I., Schwartzman, W. S., Huang, P., Han, Y. Y., Fouladian, Z., et al. (2025) · Nutrients · doi:10.3390/nu17010198 · Cited by 8
Evaluation of thyroid status in type 2 Diabetes Mellitus with Reference to insulin Resistance
Vasudevan, E., Mahadevan, Y., Shanthi, B., Anton, M. C., Jyothirmayi, B., & Sridevi, C. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3049 · Cited by 4
Lago-Sampedro, A. M., Oualla‐Bachiri, W., Maldonado‐Araque, C., Valdés, S., González-Molero, I., Doulatram‐Gamgaram, V. K., Delgado, E., Chaves, F. J., Castaño, L. A., Calle‐Pascual, A. L., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13010160 · Cited by 3
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
